Date: 2023-11-09Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of the EEA Joint Committee No 76/2023 of 28 April 2023 amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement [2023/2232]
**Summary:**
EEA Joint Committee Decision No. 76/2023, adopted on April 28, 2023, amends Annex I (Veterinary and phytosanitary matters) to the Agreement on the European Economic Area (EEA). The decision incorporates Commission Implementing Regulation (EU) 2022/2304 of November 24, 2022, which designates the European Union reference laboratory for Rift Valley fever, into the EEA Agreement.
Specifically, the decision inserts point "52. 32022 R 2304" after point "51 (Commission Delegated Regulation (EU) 2021/2156)" in Part 3.2 of Chapter I of Annex I to the EEA Agreement. This addition references Commission Implementing Regulation (EU) 2022/2304, published in the Official Journal L 305, 25.11.2022, p. 51.
This act does not apply to Iceland, concerning legislation regarding live animals other than fish and aquaculture animals, as specified in paragraph 2 of the Introductory Part of Chapter I of Annex I to the EEA Agreement. It also does not apply to Liechtenstein, regarding veterinary matters, as long as the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein.
The Decision enters into force on April 29, 2023, contingent upon the completion of all notifications required under Article 103(1) of the EEA Agreement. The Norwegian language text of Implementing Regulation (EU) 2022/2304 will be published in the EEA Supplement to the Official Journal of the European Union and will be considered authentic. The Decision will be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Key Entities Referenced
European Union: A political and economic union of member states located primarily in Europe.
EEA Joint Committee: The committee responsible for managing the EEA Agreement.
EEA Agreement: The Agreement on the European Economic Area.
Commission Implementing Regulation EU 2022/2304: Commission Implementing Regulation designating the European Union reference laboratory for Rift Valley fever.
Rift Valley fever: A viral disease that affects livestock and humans.
Iceland: A Nordic island country in the North Atlantic.
Liechtenstein: A German-speaking microstate in the Alps, between Switzerland and Austria.
Brussels: The capital of Belgium, where the decision was made.
Official Journal EN
of the European Union L series
2023/2232 9.11.2023
DECISION OF THE EEA JOINT COMMITTEE No 76/2023
of 28 April 2023
amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement [2023/2232]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2022/2304 of 24 November 2022 designating the European Union
reference laboratory for Rift Valley fever(1)is to be incorporated into the EEA Agreement.
(2) This Decision concerns legislation regarding live animals other than fish and aquaculture animals. Legislation
concerning these matters shall not apply to Iceland, as specified in paragraph 2 of the Introductory Part of Chapter I
of Annex I to the EEA Agreement. This Decision is therefore not to apply to Iceland.
(3) This Decision concerns legislation regarding veterinary matters. Legislation regarding veterinary matters shall not
apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss
Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the sectoral adaptations
to Annex I to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.
(4) Annex I to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
The following is inserted after point 51 (Commission Delegated Regulation (EU) 2021/2156) in Part 3.2. of Chapter I of
Annex I to the EEA Agreement:
‘52. 32022 R 2304: Commission Implementing Regulation (EU) 2022/2304 of 24 November 2022 designating the
European Union reference laboratory for Rift Valley fever (OJ L 305, 25.11.2022, p. 51).
This act shall not apply to Iceland.’
Article 2
The text of Implementing Regulation (EU) 2022/2304 in the Norwegian language, to be published in the EEA Supplement
to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 29 April 2023, provided that all the notifications under Article 103(1) of the EEA
Agreement have been made*.
(1) OJ L 305, 25.11.2022, p. 51.
* No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2023/2232/oj 1/2EN
OJ L, 9.11.2023
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
Done at Brussels, 28 April 2023.
For the EEA Joint Committee
The President
Nicolas VON LINGEN
2/2 ELI: http://data.europa.eu/eli/dec/2023/2232/oj